# Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD

> **NCT00418262** · PHASE3 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 27 (actual)

## Conditions studied

- Fetal Alcohol Syndrome
- Attention Deficit Hyperactivity Disorder (ADHD)

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00418262
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2015-04-22
- **Final completion:** 2015-04-22
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418262, "Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00418262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*